Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Venoco, Inc. (VQ)
|
Add to portfolio |
|
|
|
| Price: |
$12.49
| | Metrics |
| OS: |
30.3
|
M
| |
|
|
| Market cap: |
$378
|
M
| |
|
|
|
Net debt:
|
$908
|
M
| |
|
|
|
EV:
|
$1.29
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($470)
|
M
| |
|
|
|
EBIT
|
($493)
|
M
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 60.7 | 224.2 | 317.5 | 356.5 | 328.8 | 295.3 | 270.5 | 557.9 |
| Revenue growth | -72.9% | -29.4% | -10.9% | 8.4% | 11.3% | 9.2% | -51.5% | 48.2% |
| Cost of goods sold | 54.4 | 72.3 | 77.8 | 91.9 | 94.1 | 84.3 | 95.2 | 976.6 |
| Gross profit | 6.4 | 151.9 | 239.7 | 264.6 | 234.7 | 211.0 | 175.3 | -418.7 |
| Gross margin | 10.5% | 67.7% | 75.5% | 74.2% | 71.4% | 71.5% | 64.8% | -75.1% |
| Selling, general and administrative | | | | | | | | 0.0 |
| General and administrative | 29.1 | 20.4 | 50.7 | 55.2 | 39.2 | 37.6 | 36.9 | 0.0 |
| EBIT | -493.2 | 76.3 | 134.0 | 102.0 | 87.5 | 72.9 | 33.1 | -418.7 |
| EBIT margin | -812.2% | 34.0% | 42.2% | 28.6% | 26.6% | 24.7% | 12.2% | -75.1% |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -379.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.3 | -14.4 | 11.2 |
| Tax rate | | | | | | | | |
| Earnings from continuing ops | -505.0 | 84.6 | -28.4 | -49.5 | 62.3 | 67.5 | -47.3 | -391.1 |
| Earnings from discontinued ops | | | | | | | | -391.1 |
| Net income | -505.0 | 84.6 | -28.4 | -49.5 | 62.3 | 67.5 | -47.3 | -391.1 |
| Net margin | -831.7% | 37.7% | -9.0% | -13.9% | 19.0% | 22.9% | -17.5% | -70.1% |
| |
| Diluted EPS | | | | | $1.07 | $1.27 | ($0.93) | ($7.75) |
| Shares outstanding (diluted) | | | | | 58.2 | 53.0 | 50.8 | 50.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|